Calcineurin.
Hogan
Patrick G
PG
The CBR Institute for Biomedical Research and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA. hogan@cbr.med.harvard.edu
Li
Huiming
H
D000818:Animals; D001327:Autoimmune Diseases / Q000378:metabolism; D001921:Brain / Q000378:metabolism*; D019703:Calcineurin / Q000737:chemistry* / Q000502:physiology*; D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000494:pharmacology; D004268:DNA-Binding Proteins / Q000378:metabolism; D019281:Dimerization; D006084:Graft Rejection; D006801:Humans; D008322:Mammals / Q000378:metabolism; D050778:NFATC Transcription Factors; D009687:Nuclear Proteins / Q000378:metabolism; D011487:Protein Conformation; D013379:Substrate Specificity; D016559:Tacrolimus / Q000494:pharmacology; D014157:Transcription Factors / Q000378:metabolism
D065095:Calcineurin Inhibitors; D004268:DNA-Binding Proteins; D050778:NFATC Transcription Factors; D009687:Nuclear Proteins; D014157:Transcription Factors; D016572:Cyclosporine; D019703:Calcineurin; D016559:Tacrolimus